Bioactive Compounds
-
A4511 CercosporamideTarget: JAK|MNKSummary: Mnk2 and JAK3 inhibitor -
A5010 AsenapineSummary: Inhibits adrenergic receptor/5-HT receptor -
A8357 AG-1478Target: EGFRSummary: EGFR inhibitor,potent and selective -
A8488 NVP-BGT226Target: PI3K|mTORSummary: PI3K/mTOR inhibitor,selective and novel -
A8377 BetacaroteneSummary: Red-orange pigment,carotenoid -
A8640 Flavopiridol hydrochlorideSummary: CDK inhibitor, potent and selective -
A8648 Oxaliplatin12 CitationSummary: platinum-based chemotherapeutic agent -
B3227 CNX-2006Summary: mutant-EGFR inhibitor, selective and irreversible -
A3896 Tulathromycin ASummary: Triamilide antimicrobial -
A1123 Amyloid Beta-Peptide (12-28) (human)Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH
